The Hungarian government is subsidising an expansion of pharmaceutical company Pannonpharma’s plant in Pécsvárad, southern Hungary, designed to manufacture drugs against the coronavirus, Finance Minister Mihály Varga said. The plant, built with a 1.6 billion (EUR 4.6m) forint investment, will produce an interferon-based gel designed to activate the immune system supressed by the virus, and a pill with the same active substance to eliminate coronavirus in the stomach and intestines. Varga said in a video message that a growing number of domestically produced, high-quality health-care products ensure Hungary’s independence from foreign manufacturers. The government’s health-care development scheme has already yielded results, Varga said. The Health Industry Development Programme has so far supported 82 investments worth a total of 86 billion forints (EUR 246.0m), 31 of which, totalling at 37 billion forints, have already been implemented, he said. The number of jobs saved by the investments may reach 5,700, he said.